1. Home
  2. Catalog
  3. Tirzepatide
PEPTAURA
  1. Home
  2. Catalog
  3. Tirzepatide
HomeCatalogSuppliersCOAsShippingVerify

Site Map

HomeCatalogRFQFAQVerifySuppliersCOAsBecome an AffiliateSellers PortalContact

Legal

DisclaimersPrivacy Policy

© 2026 peptaura.com, All Rights Reserved.

TIRZEPATIDE

Dose per Vial/Cartridge

Latest Research

PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC.

2026 Apr 10

Abbasi J

Open

Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6.

2026 Apr 10

Bajaj HS, Billings LK, Sharma P, Levine JA, Rodriguez A, Patel H

Open

Targeting the activin/myostatin - actrii pathway to preserve skeletal muscle mass in obesity: mechanistic insights and therapeutic perspectives.

2026 Apr 9

Lisco G, De Tullio A, Disoteo OE, Dicorato P, Tortora A, De Geronimo V, Triggiani V

Open

Tolerability and Effectiveness of Tirzepatide in Kidney Transplant Recipients: Real-world Experience From a Single-center Study.

2026 Apr 9

Hussain SM, Malat G, Tandukar S, Trofe J, Potluri V, Lim MA

Open

Real-world weight impact upon tirzepatide discontinuation at a single-center endocrinology clinic in patients with overweight or obesity.

2026 Apr 8

Huang L, Lee A, Kim D, Tungate S, Komé A, Yang A

Open

Genetic predictors of GLP1 receptor agonist weight loss and side effects.

2026 Apr 8

Su QJ, Ashenhurst JR, Xu W, Tran V, Ryanne Wu R, Weldon CH, Shi J, Hicks B, 23andMe Research Team, Abul-Husn NS, Aslibekyan S, Holmes MV, Koelsch BL, Auton A

Open

Acute onset of neovascular age-related macular degeneration after initiation of tirzepatide.

2026 Apr

Takebayashi K, Iemura Y, Yamauchi M, Hara K, Tsuchiya T, Machida S, Hashimoto K

Open

Tirzepatide in Metabolically Dysfunctional-Associated Steatohepatitis (MASH): A Bibliometric and Evidence-Based Review.

2026

Pantea I, Repanovici A

Open

Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence.

2026

Parizad R, Hatwal J, Taban Sadeghi M, Brar A, Desai R, Batta A, Mohan B

Open

Cardiovascular adverse event reporting profile of tirzepatide: a real-world pharmacovigilance analysis of heart failure, arrhythmias, and ischemic events.

2026

Chen D, Wang Z, Xie Z, Chen Y, Luo S, Xu S

Open